Impact

Live product traction, reported carefully.

The metrics below are configured centrally and can be switched to verified when validated source material is available.

2

care organizations live

Pilot clinical deployments . Active clinical partner sites
340

cases structured

Across partner sites . Internal case logs
18

clinicians using Ireti

Active users . Internal user records
42

tumor board reviews prepared

Multidisciplinary reviews . Internal workflow logs

Institution ecosystem

Hospitals
Pathology labs
Molecular diagnostics
Cancer networks
Research teams
Specialist clinics

Healthcare partners live on Ireti

Real clinical implementations demonstrating how institutions use Ireti and their measured outcomes.

Greencare Hospital - Multidisciplinary Tumor Board
Tertiary Hospital & Cancer Center

Greencare Hospital

Lagos, Nigeria

Tertiary specialist hospital & multidisciplinary cancer care department

How they use the tech

Ingests scanned histopathology reports, IHC biomarker panels, and radiology findings across surgical, medical, and radiation oncology teams to assemble unified digital dossiers prior to weekly tumor board reviews.

Their clinical output

Case preparation time cut from 4.5 hours to 45 minutes (-80%); 100% source-traceable clinical summaries and signed-off treatment plans across 220+ patient reviews.

Domlan Diagnostics - Molecular Pathology & Genomics Unit
Molecular Pathology Reference Lab

Domlan Diagnostics

Lagos & Abuja, Nigeria

Specialist reference laboratory providing molecular oncology and cancer biomarker diagnostics

How they use the tech

Processes raw molecular assay outputs and genomic mutation panels (EGFR, KRAS, BRAF, HER2), structuring variant data into traceable clinical summaries directly accessible to referring oncology networks.

Their clinical output

Zero transcription errors in molecular biomarker handoffs, instant automated matching against NCCN/ESMO evidence guidelines, and direct digital reporting to 120+ referring cancer specialists.